CAS RN: 93111-27-4
4-FLUOROBENZALDEHYDE-2,3,5,6-D4
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98 atom% D (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250212
10mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 93111-27-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Beijing
Inquiry
93111-27-4 / 2,3,5,6-tetradeuterio-4-fluorobenzaldehyde
Standard CAS: 93111-27-4
Multi CAS: Yes
Basic Information
copy
CAS
93111-27-4 copy
Multi CAS
Yes copy
Molecular Formula
C7FH5O copy
Molecular Weight
128.140000 copy
Exact Mass
128.057550 copy
InChI
InChI=1S/C7H5FO/c8-7-3-1-6(5-9)2-4-7/h1-5H/i1D,2D,3D,4D copy
InChIKey
UOQXIWFBQSVDPP-RHQRLBAQSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Aromatic heavy atom count
6 copy
Rotatable bonds
1 copy
H-bond acceptors
1 copy
Molar refractivity
31.79 copy
TPSA
17.07 copy
LogP / Solubility
WLOGP
1.64 copy
MLOGP
1.43 copy
XLogP3
1.6 copy
Consensus LogP
1.56 copy
Log S (ESOL)
-2.07 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.76 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.95 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.31 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy